Handheld Capillary Blood Lactate Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and Heart Failure Occurrence during Long-Term Follow-Up

Table 5

Cox regression model for heart failure occurrence in one year of follow-up.

Endpoint II	⁢Univariate Cox regression analysis			⁢Multivariate Cox regression analysis
	HR	95% CI		HR	95% CI
AF	3.53	(0.96–12.98)	0.05	—	—	—
BMI	1.12	(1.01–1.24)	0.03	1.20	(1.07–1.35)	0.002
CREAT	1.03	(1.01–1.04)	0.001	1.04	(1.02–1.06)	0.0004
GPIIb/IIIa	3.01	(1.03–8.78)	0.04	5.00	(1.52–16.42)	0.007
IABP	8.23	(1.03–66.06)	0.04	—	—	—
LC	1.17	(1.04–1.31)	0.01	1.21	(1.05–1.40)	0.007
%	4.53	(1.39–14.82)	0.01	—	—	—
Diabetes	2.73	(0.94–7.96)	0.06	—	—	—
Shock	5.39	(1.46–19.88)	0.01	—	—	—
STEMI	2.59	(0.85–7.91)	0.09	—	—	—
WBC	1.12	(0.99–1.25)	0.06	—	—	—

AF: atrial fibrillation. BMI: body mass index. CREAT: creatinine. GPIIb/IIIa: glycoprotein IIb/IIIa inhibitors. IABP: intra-aortic balloon pump. LC: lactate concentration. LM: left main coronary artery. STEMI: ST elevation myocardial infarction. WBC: white blood cells.